1.Expression of Glucose Transporter Gene in Colorectal Cancer.
Suk Hwan LEE ; Jae Hoon PARK ; Yoon Wha KIM ; Soo Myung OH ; Choong YOON ; Hoong Zae JOO ; Kee Hyung LEE
Journal of the Korean Society of Coloproctology 2000;16(2):57-66
PURPOSE: The primary metabolic characteristic of malignant cells is an increased uptake of glucose and its anaerobic glycolysis. Recent studies have demonstrated that facilitative glucose transport across the plasma membrane is mediated by a family of proteins, i.e., glucose transporters. PURPOSE: In order to evaluate the clinicopathologic correlations of glucose transporter genes expressed in colorectal cancer, the author studied the expression of glucose transporter genes in human colorectal cancer and analyzed their expression in normal and malignant colorectal tissues. METHODS: A reverse transcriptase-polymerase chain reaction (RT-PCR) was applied to quantitatively determine the levels of the glucose transporter genes, GLUT1 and GLUT3, from Crohnes diseases (N=2), adenomatous polyps (N=4), and colorectal cancers (N=40) and their normal counterparts. RESULTS: The expresssion of the GLUT1 gene was detected in 50% of the inflammatory colonic mucosae and adenomatous polyp tissues, but the levels of expression were not significantly different from their normal counterparts. Among the 40 colorectal cancer patients, 23 patients (57.5%) showed GLUT1 gene expression and the levels of expression were increaed by 1.8 as compared to their normal counterparts (p<0.05). The expression of the GLUT3 gene was detected in almost all tissues examined, and the levels of expression were not significantly different from their normal counterparts. In colorectal cancers, there was correlation between GLUT1 expression, the extent of lymph node involvement and the stage of colorectal cancers (p<0.05). But, the correlation between the expressions of the GLUT3 gene and the clinicopathologic prognostic factors of colorectal cancers could not be determined because almost all tissues showed a GLUT3 gene expression. CONCLUSIONS: In conclusion, the GLUT1 glucose transporter expression in colorectal cancer was associated with high possibilities of lymph node metastases and poorer prognosis, and the assessment of GLUT1 expression in colorectal cancer would be useful in identifying high risk patients.
Adenomatous Polyps
;
Cell Membrane
;
Colon
;
Colorectal Neoplasms*
;
Gene Expression
;
Glucose Transport Proteins, Facilitative*
;
Glucose*
;
Glycolysis
;
Humans
;
Lymph Nodes
;
Mucous Membrane
;
Neoplasm Metastasis
;
Prognosis
2.Prospective Clinical Study of Prophylactic Antibiotic Therapy in Nonperforated Appendicitis.
Seong Hee KANG ; Sung Wook KIM ; Ik Haeng JO ; Kyung Sun HWANG ; Suk Zae PARK ; Chan Dong KIM ; Jung Su KIM ; Jun Hong MIN ; Dae Hyun YANG ; Jin YOUN ; Sang Su PARK ; Il Myung KIM ; Byung Ook YOO ; Won Jin CHOI
Journal of the Korean Surgical Society 2000;58(6):824-833
PURPOSE: Prophylactic antibiotics have been used in nonperforated appendicitis for preventing infection after an appendectomy. However, the duration of antibiotic administration for surgical prophylaxis in Korea has been noted to be longer than those recommended in other countries. PURPOSE: The objective of this study was to identify the appropriate duration of prophylactic antibiotic therapy in nonperforated appendicitis by comparing the wound infection rates of two different antibiotic regimens, 24 hours of cephalosporin (cefoxitin) alone and 72 hours of cephalosporin (cefoxitin) with aminoglycoside (sissomicin). METHODS: One hundred thirty-four (134) patients of nonperforated appendicitis were enrolled in this prospective, randomized, open trial and were assigned to one of two antibiotic regimens: 1) cefoxitin 1 g every 8 hours given intravenously for 24 hours and 2) cefoxitin 1 g every 8 hours given intravenously plus sissomicin 75 mg every 12 hours given intramuscularly for 72 hours. First doses were given just prior to the induction of anesthesia. RESULTS: Postoperative wound infections were detected in 3 cases (4.5%) of the 72-hour-treated group (n=66) whereas none occurred in the 24-hour-treated group (n=68). However, the difference in the rates of wound infections between the two groups was not statistically significant. Cost analysis identified a saving of 43,470 won per patient in the 24-hour-treated group. CONCLUSION: In nonperforated appendicitis cefoxitin administration alone for 24 hours is sufficient as a surgical prophylaxis.
Anesthesia
;
Anti-Bacterial Agents
;
Appendectomy
;
Appendicitis*
;
Cefoxitin
;
Costs and Cost Analysis
;
Humans
;
Korea
;
Prospective Studies*
;
Sisomicin
;
Surgical Wound Infection
;
Wound Infection